Sep. 22 at 10:48 PM
$TRAW have a look at the other biotech company that Squadron Capital Management recently invested in, and their stock performance since August 2025 when they filed their most recent increase. And Squadron just took a 6% position in TRAW on Sept 19, 2025. I would expect a very solid increase in TRAW stock price over the coming fall. Not only a long Covid as well as a therapeutic for bird flu which is currently experiencing a massive resurgence throughout the world and has only a matter of time (when not if) it (unfortunately) becomes capable of human to human transmission. Add to it that Dr. Redfield is attending round table with RFK and current U.S. health leadership. This feels like a 10x opportunity at minimum (IMHO).
